CMMI has made an important change to the Enhancing Oncology Model (EOM) for a second enrollment period beginning July 1, 2025 (Performance Period 4). The change resets the neutral zone between the benchmark and target price, rather than at 98% of the benchmark. This...
August 23, 2022 Deep Risk Management’s CEO, Brian Kern, was featured on The Healthcare Maze podcast to discuss the advantages and disadvantages of physician organizations participating in value-based care. Listen to the podcast here:...
Detailed guidance on the CMS “built-in” stop loss for the Global and Professional Direct Contracting (GPDC) model was released on January 7, 2022. DCEs that want to meaningfully compare this coverage to the market will need a highly specialized risk...
Disputes over value-based care arrangements have become common, as payors and providers often lack a clear understanding of agreement terms. Risk, data-sharing, and calculation methodologies are typically at the center of disputes. Read about a recent dispute in NJ...
